Subscribe
CURE spoke with Bruce D. Cheson to gain a deeper understanding of adding the targeted therapy Gazyva to the chemotherapy Treanda for patients with Rituxan-refractory indolent non-Hodgkin lymphoma.
A Focus on a Cure for Non-Hodgkin Lymphoma
Pipeline
259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512
609-716-7777